The effect of gantry angle on megavoltage photon beam attenuation by a carbon fiber couch insert

The use of rigid carbon fiber couch inserts in radiotherapy treatment couches is a well-established method of reducing patient set-up errors associated with couch sag. Several published studies have described such inserts as radiotranslucent with negligible attenuation of the radiation field. Most of these studies were conducted with the radiation field normally incident on the couch and there appears to be no evidence in the literature of the effect of the gantry angle on the extent of beam attenuation by the carbon fiber insert alone during external beam radiotherapy. In this study we examined the magnitude of this effect over a range of posterior oblique gantry angles using a cylindrical solid water phantom containing an ionization chamber placed isocentrically. It was found that a 6 MV photon beam, field size 10 x 5 cm, was attenuated significantly as the gantry angle approached the plane of the couch, from 2% at normal incidence and reaching 9% attenuation at angle of incidence 70 degrees. This could have serious implications regarding dose to the treatment volume for treatments requiring posterior oblique angles of incidence with a possible correction factor necessary in monitor unit calculations.     

Variations in skin dose associated with linac bed material at 6 MV x-ray energy

Treatment with radiotherapy x-rays at 6 MV energy produces a build-up effect whereby a smaller dose is delivered to the patient's skin compared to the tumour dose. With anterior fields, no material is normally placed over the patient's skin, thus providing the maximum skin sparing possible with the beam configuration used. A posterior beam normally passes through the treatment couch top and increases the dose delivered to the patient's skin. Both the Mylar sheeting and the support ribbing material produce a significant increase in skin dose. Measurements at 6 MV have shown that the basal cell layer dose can be increased by up to 51% of maximum dose with a carbon fibre/Mylar couch and by 28% for a tennis string/Mylar couch when compared to anterior beams. These values are associated with the position of the carbon fibre or tennis string ribbing. Dermal layer doses are increased by up to 30 and 24% of maximum dose for carbon fibre and tennis string, respectively. These values include a combination of dose due to the support ribbing and the Mylar sheeting. Due to the variability in patient positioning on the couch top, these increases would be spread out over the skin surface producing an average increase per unit area at the basal layer of up to 32 and 20% of the maximum, respectively, for carbon fibre and tennis string couch tops and 21 and 12% at the dermal layer compared to dose at Dmax.     

Surface and build-up region dosimetry for obliquely incident intensity modulated radiotherapy 6 MV x rays

This study investigates the surface dose and build-up region dosimetry for oblique IMRT beams. The dependence of surface and build-up region doses of 0 degrees (perpendicular incidence) and 75 degrees (oblique incidence) IMRT fields on field size was measured and compared with open field dosimetry. Measurements were performed using a parallel-plate chamber and KODAK EDR2 films in a polystyrene phantom for a 6 cm x 6 cm and a 12 cm x 12 cm, 6 MV photon beam at depths of 0 mm (surface) through dmax. Data were normalized to the dmax value of each field. Four intensity modulated delivery patterns were created and delivered using step-and-shoot IMRT: (1) six static 1 cm x 6 cm strips (IMRTstrip), (2) 12 static 1 cm x 12 cm strips (IMRTstrip), (3) intensity modulated beam patterns created by using the inverse planning optimization software (IMRTopt) for 6 cm x 6 cm, and (4) IMRTopt for 12 cm x 12 cm field sizes. The percent depth doses (PDDs) of 0 degrees, 6 cm x 6 cm IMRTstrip beam at the surface and 5 mm were lower by 8.8% and 1.6%, respectively, compared to the open field. The PDDs of 75 degrees, 6 cm x 6 cm IMRTstrip beam at the surface and 5 mm were lower by 6.7% and 2.4%, respectively, compared to the open field. This study showed that IMRT itself is not contributing to greater skin doses.     

Measurement of radiotherapy x-ray skin dose on a chest wall phantom

Sufficient skin dose needs to be delivered by a radiotherapy chest wall treatment regimen to ensure the probability of a near surface tumor recurrence is minimized. To simulate a chest wall treatment a hemicylindrical solid water phantom of 7.5 cm radius was irradiated with 6 MV x-rays using 20x20 cm2 and 10x20 cm2 fields at 100 cm source surface distance (SSD) to the base of the phantom. A surface dose profile was obtained from 0 to 180 degrees, in 10 degrees increments around the circumference of the phantom. Dosimetry results obtained from radiochromic film (effective depth of 0.17 mm) were used in the investigation, the superficial doses were found to be 28% (of Dmax) at the 0 degrees beam entry position and 58% at the 90 degrees oblique beam position. Superficial dose results were also obtained using extra thin thermoluminescent dosimeters (TLD) (effective depth 0.14 mm) of 30% at 0 degrees, 57% at 90 degrees, and a metal oxide semiconductor field effect transistor (MOSFET) detector (effective depth 0.5 mm) of 43% at 0 degrees, 62% at 90 degrees. Because the differences in measured superficial doses were significant and beyond those related to experimental error, these differences are assumed to be mostly attributable to the effective depth of measurement of each detector. We numerically simulated a bolus on/bolus off technique and found we could increase the coverage to the skin. Using an alternate "bolus on," "bolus off" regimen, the skin would receive 36.8 Gy at 0 degrees incidence and 46.4 Gy at 90 degrees incidence for a prescribed midpoint dose of 50 Gy. From this work it is evident that, as the circumference of the phantom is traversed the SSD increases and hence there is an inverse square fluence fall-off, this is more than offset by the increase in skin dose due to surface curvature to a plateau at about 90 degrees. Beyond this angle it is assumed that beam attenuation through the phantom and inverse square fall-off is causing the surface dose to reduce.     

Measurement of superficial dose from a static tomotherapy beam

Superficial doses were measured for static TomoTherapy Hi-Art beams for normal and oblique incidence. Dose was measured at depths < or = 2 cm along the central axis of 40 x 5 cm2 and 40 x 2.5 cm2 beams at normal incidence for source to detector distances (SDDs) of 55, 70, and 85 cm. Measurements were also made at depths normal to the phantom surface for the same beams at oblique angles of 30 degrees, 45 degrees, 60 degrees, 75 degrees, and 83 degrees from the normal. Data were collected with a Gammex/RMI model 449 parallel-plate chamber embedded in a solid water phantom and with LiF thermoluminescent dosimeters (TLDs) in the form of powder. For comparison, measurements were made on a conventional 6 MV beam (Varian Clinac 2100C) at normal incidence and at an oblique angle of 60 degrees from the normal. TomoTherapy surface dose varied with the distance from the source and the angle of incidence. For normal incidence, surface dose increased from 0.16 to 0.43 cGy/MU as the distance from the source decreased from 85 to 55 cm for the 40 x 5 cm2 field and increased from 0.12 to 0.32 cGy/MU for the 40 x 2.5 cm2 field. As the angle of incidence increased from 0 degrees to 83 degrees, surface dose increased from 0.24 to 0.63 cGy/MU for the 40 x 5 cm2 field and from 0.18 to 0.58 cGy/MU for the 40 x 2.5 cm2 field. For normal incidence at 55 cm SDD, the surface dose relative to the dose at d(max) for the 40 x 5 cm2 TomoTherapy Hi-Art beam was 31% less than that from a conventional, flattening filter based linear accelerator. These data should prove useful in accessing the accuracy of the TomoTherapy treatment planning system to predict the dose at superficial depths for a static beam delivery.     

Dosimetric characteristics of wedges mounted beyond the blocking tray.

In a beam accessory configuration for a linear accelerator using a prototype multileaf collimator, newly designed wedges were mounted beyond the blocking tray. The isodose curves, depth of maximum dose, surface dose, and wedge transmission factors were measured for the wedges designed for this unique configuration. The same set of wedges was used for both 6- and 18-MV x rays. The shape of the wedged isodose curves was essentially unchanged from those produced by the conventional wedges located above the blocking tray. The isodose curves exhibited the desired wedge angles over the range of field sizes from 5 x 5 to 15 x 40 cm. In the 10 x 10-cm field, the average difference between the observed wedge angle and the desired wedge angle was 3.8 degrees. The surface doses ranged from 18% to 35% for the wedged 10 x 10-cm fields as compared with about 15% for the same open field. Dosimetrically the wedges were acceptable for clinical use.     

全脑全脊髓转床半野照射技术的临床应用

目的：介绍一种通过转床、半野进行全脑全脊髓照射的技术。方法：模拟定位时首先设颈胸脊髓野：机架角O°,小机头0°,床角0°,SSD=100cm,野长40cm,野宽4cm～5cm,同时在体膜上标记射野上界（B点）和下界（C点）,然后设全脑野：使用半束左右两野对穿照射,机架角90°或270°,小机头11.3°或348．7°,床角0°,SAD=100cm,Y1=0,X和Y2取包括颅骨外1cm,使射野X方向中心线在透视下与B点重合,最后设腰骶脊髓野：以C点为中心使用半束照射,机架角11.3°,小机头O°,床角90°,SSD=100cm,X2=0,Y和X1取包括腰骶直至S4。同时使用Kodak-Ec-film胶片、固体水模体以及MatriXX系统在加速器治疗机上模拟射野进行射野衔接点的几何和剂量验证,并观察12例使用该技术投照期间患者的放疗反应。结果：颈胸段脊髓野与全脑野衔接点以及颈胸段脊髓野与下位脊髓野衔接点处射野边界清晰锐利,未见射野间分离和重合现象,等剂量线基本平滑,未见明显的凹陷和凸出现象,12例患者都完成全脑全脊髓的照射计划,未见明显严重的放疗反应。结论：全脑全脊髓转床半野照射技术做到了射野间的无缝衔接,方法简便,值得临床推广应用。     

Surface dosimetry for oblique tangential photon beams: a Monte Carlo simulation study

The effect of beam obliquity on the surface relative dose profiles for the tangential photon beams was studied. The 6 and 15 MV photon beams with 4 x 4 and 10 x 10 cm2 field sizes produced by a Varian 21 EX linear accelerator were used. Phase-space models of the photon beams were created using Monte Carlo simulations based on the EGSnrc code, and were verified using film measurements. The relative dose profiles in the phantom skin, at 2 mm depth from the surface of the half-phantom geometry, or HPG, were calculated for increasing gantry angles from 270 to 280 deg clockwise. Relative dose profiles of a full phantom enclosing the whole tangential beam (full phantom geometry, or FPG) were also calculated using Monte Carlo simulation as a control for comparison. The results showed that, although the relative dose profiles in the phantom skin did not change significantly with an oblique beam using a FPG, the surface relative depth dose was increased for the HPG. In the HPG, with 6 MV photon beams and field size = 10 x 10 cm2, when the beam angle, starting from 270 deg, was increased from 1 to 3 deg, the relative depth doses in the phantom skin were increased from 68% to 79% at 10 cm depth. This increase in dose was slightly larger than the dose from 15 MV photon beams with the same field size and beam angles, where the relative depth doses in phantom skin were increased from 81% to 87% at 10 cm depth. A parameter called the percent depth dose (PDD) ratio, defined as the relative depth dose from the HPG to the relative depth dose from the FPG at a given depth along the phantom skin, was used to evaluate the effect of the phantom-air interface. It is found that the PDD ratio increased significantly when the beam angle was changed from zero to 1-3 degrees. Moreover, the PDD ratio, for a given field size, experienced a greater increase for 6 MV than for 15 MV. For the same photon beam energy, the PDD ratio increased more with a 4 x 4 cm2 field compared to 10 x 10 cm2. The results in this study will be useful for physicists and dosimetrists to predict the surface relative dose variations when using clinical tangential-like photon beams in radiation therapy.     

Ultra-thin TLDs for skin dose determination in high energy photon beams

Estimation of surface dose is very important for patients undergoing radiation therapy. In this work we investigate the dose at the surface of a water phantom and at a depth of 0.007 cm, the practical reference depth for skin as recommended by ICRP and ICRU, with ultra-thin TLDs and Monte Carlo calculations. The calculations and measurements were carried out for fields ranging from 5 x 5 cm2 to 20 x 20 cm2 for 6 MV, 10 MV and 18 MV photon beams. The variation of the surface dose with angle of incidence and field size was investigated. Also, the exit dose was computed and measured for the same fields and angles of incidence. The dose at the ICRU reference depth was computed. Good agreement (+/-5%) was achieved between measurements and calculations. The surface dose at the entrance increased with the angle of incidence and/or the field size. The exit dose decreased with the angle of incidence but it increased with field size. The dose at the surface of the patient is mostly dependent on the beam energy, modality and beam obliquity rather than the field size and field separation. By correlating TLD measurements with Monte Carlo calculations, we were able to predict the dose at the skin surface with good accuracy. Knowing the dose received at the surface of the patient can lead to prediction of skin reactions helping with the design of new treatment techniques and alternative dose fractionation schemes.     

Peripheral dose outside applicators in electron beams

The peripheral dose outside the applicators in electron beams was studied using a Varian 21 EX linear accelerator. To measure the peripheral dose profiles and point doses for the applicator, a solid water phantom was used with calibrated Kodak TL films. Peak dose spot was observed in the 4 MeV beam outside the applicator. The peripheral dose peak was very small in the 6 MeV beam and was ignorable at higher energies. Using the 10 x 10 cm(2) cutout and applicator, the dose peak for the 4 MeV beam was about 12 cm away from the field central beam axis (CAX) and the peripheral dose profiles did not change with depths measured at 0.2, 0.5 and 1 cm. The peripheral doses and profiles were further measured by varying the angle of obliquity, cutout and applicator size for the 4 MeV beam. The local peak dose was increased with about 3% per degree angle of obliquity, and was about 1% of the prescribed dose (angle of obliquity equals zero) at 1 cm depth in the phantom using the 10 x 10 cm(2) cutout and applicator. The peak dose position was also shifted 7 mm towards the CAX when the angle of obliquity was increased from 0 to 15 degrees.     

Elekta Infinity直线加速器治疗床对放疗剂量的影响

目的:研究Elekta Infinity直线加速器治疗床在常用X射线能量下对放疗剂量的影响。方法:将圆柱体模体分别置于碳纤维主治疗床、延长板以及治疗床与延长板衔接处正中,旋转机架,分别让6和10 MV高能X射线穿过治疗床,利用指形电离室测量固体水中间的绝对剂量,得出不同角度下的剂量分布,并计算治疗床对X射线的衰减因子。结果:治疗床与延长板衔接处在120°和240°两个机架角处的剂量衰减因子在6和10 MV两种治疗模式下分别达到了36.02%和36.01%以及30.46%和30.63%,而当机架角为140°~220°时,衔接处与主治疗床的剂量衰减因子相近,在6与10 MV能量下的剂量衰减因子平均值及标准差分别为2.56%±0.49%和2.14%±0.39%以及2.55%±0.48%和1.95%±0.41%,机架角由180°增大或减小时两处的剂量衰减均呈上升趋势,二者均在120°和240°附近达到最大;6和10 MV两种能量下延长板在该角度区间的剂量衰减因子平均值及标准差分别为1.55%±0.24%和1.07%±0.25%,并在115°和245°附近达到最大值,剂量衰减因子分别为4.08%和3.97%以及3.20%和3.34%。结论:后斜野主体部分在主治疗床与衔接处对剂量的衰减低于3%,在延长板处对剂量的衰减小于2%,但在120°和240°附近以及115°和245°附近3处位置的剂量衰减会达到最大,需在计划系统中考虑床的影响;此外,主治疗床与延长板衔接处在120°和240°附近对剂量的衰减急剧增大,不适合作为治疗区域,在治疗病人时需注意避免将靶区移到该区域。     

碳素纤维床CT值对头部肿瘤放疗计划剂量分布的影响

目的:定量分析碳素纤维床CT值对头部肿瘤放疗计划剂量分布的影响。方法:在Varian Eclipse 13.6计划系统中建立9种不同CT值的碳素纤维床和均匀圆柱水模体模型,并将圆柱水模体放置于碳素纤维床中间,在10 cm[×]10 cm射野下,采用6 MV X射线机架在0°~180°之间以10°为间隔行等中心照射,计算不同CT值的碳素纤维床的吸收剂量差异系数。选取头部肿瘤患者15例,以Eclipse计划系统提供的默认CT值碳素纤维床为基础,设计放疗计划,并将该计划保存为模板计划。随后将模板计划移植至其余8种不同CT值的碳素纤维床图像中,不进行通量优化,重新计算剂量分布。记录9种不同CT值碳素纤维床计划的D2%、D50%、D98%、CI、HI以及GI。结果:在-700 HU至-300 HU内,随着Panel Surface CT值的增加,吸收剂量差异系数逐渐减小;在-1 000 HU至-900 HU内,随着Panel Interior CT值的增加,吸收剂量差异系数逐渐增大。默认CT值的碳素纤维床计划与其他8种碳素纤维床计划的D2%、D50%、D98%,以及GI差异具有统计意义（P<0.05）,而HI则无统计学差异（P>0.05）。结论:物理师在设计放疗计划时,应根据实测治疗床的CT值构建碳素纤维床模型。     

A method of beam-couch intersection detection

At the time of treatment planning it would be useful to know whether part of the treatment beam passes through the patient/couch support assembly before it passes through the patient. In the previous work of Yorke, the range of gantry angles leading to beam-couch intersection was found as a function of couch translation for symmetric field sizes and for zero couch rotation. Yorke's method has been extended to include couch rotation, dual independent jaws, and multi-leaf collimator (MLC) field shapes. In addition, the new method is also applicable in the situation of the couch top located above the isocenter. For a clinically treatable, 20 x 20 cm field configuration in a linac, the range of gantry angles leading to beam-couch intersection are different by 6.7 degrees for a couch rotation angle of 25 degrees when compared to no couch rotation. The new method agrees with data within the setup and measurement uncertainties for a variety of field sizes including an oval shaped MLC field, and various couch locations, couch, and collimator rotation angles.     

Comparison of build-up dose between Elekta and Varian linear accelerators for high-energy photon beams using radiochromic film and clinical implications for IMRT head and neck treatments

Skin toxicity has been reported for IMRT of head and neck cancer. The purpose of this study was to investigate the dose in the build-up region delivered by a 6 MV treatment plan for which important skin toxicity was observed. We also investigated if the different designs of the treatment head of an Elekta and a Varian linear accelerator, especially the lower position of the Varian multi-leaf collimator, give rise to different build-up doses. For regular square open beams, the build-up dose along the central beam axis is higher for the Varian machine than for the Elekta machine, both for 6 MV and 18 MV. At the Elekta machine at 18 MV, the superficial dose of a diamond shaped 10 x 10 cm2 field is 3.6% lower than the superficial dose of a regular 10 x 10 cm2 field. This effect is not seen at 6 MV. At the Varian machine, the superficial dose of the diamond shaped field is respectively 3.5 and 14.2% higher than the superficial dose of the regular 10 x 10 cm2 field for 6 MV and 18 MV. Despite the differences measured in build-up dose for single beams between the Elekta and the Varian linear accelerator, there were no measurable differences in superficial dose when a typical IMRT dose plan of 6 MV for a head and neck tumour is executed at the two machines.     

Dose delivered from Varian's CBCT to patients receiving IMRT for prostate cancer

With the increased use of cone beam CT (CBCT) for daily patient setup, the accumulated dose from CBCT may be significantly higher than that from simulation CT or portal imaging. The objective of this work is to measure the dose from daily pelvic scans with fixed technical settings and collimations. CBCT scans were acquired in half-fan mode using a half bowtie and x-rays were delivered in pulsed-fluoro mode. The skin doses for seven prostate patients were measured on an IRB-approved protocol. TLD capsules were placed on the patient's skin at the central axis of three beams: AP, left lateral (Lt Lat) and right lateral (Rt Lat). To avoid the ring artefacts centred in the prostate, the treatment couch was dropped 3 cm from the patient's tattoo (central axis). The measured AP skin doses ranged 3-6 cGy for 20-33 cm separation. The larger the patient size the less the AP skin dose. Lateral doses did not change much with patient size. The Lt Lat dose was approximately 4.0 cGy, which was approximately 40% higher than the Rt Lat dose of approximately 2.6 cGy. To verify this dose asymmetry, surface doses on an IMRT QA phantom (oval shaped, 30 cm x 20 cm) were measured at the same three sites using TLD capsules with 3 cm table-drop. The dose asymmetry was due to: (1) kV source rotation which always starts from the patient's Lt Lat and ends at Lt Lat. Gantry rotation gets much slower near the end of rotation but dose rate stays constant and (2) 370 degrees scan rotation (10 degrees scan overlap on the Lt Lat side). In vivo doses were measured inside a Rando pelvic heterogeneous phantom using TLDs. The left hip (femoral head and neck) received the highest doses of approximately 10-11 cGy while the right hip received approximately 6-7 cGy. The surface and in vivo doses were also measured for phantoms at the central-axis setup. The difference was less than approximately 12% to the table-drop setup.     

DPM蒙特卡罗剂量计算算法在均匀组织和非均匀组织剂量精确性的验证

验证DPM蒙特卡罗剂量计算算法预测均匀组织和非均匀组织剂量的精确性。DPM分别计算:①6 MeV单能光子3cm×3cm照射野和Varian 60℃加速器源水模体百分深度剂量曲线和10cm深度处离轴比;②6 MeV单能光子3cm×3cm、10cm×10cm照射野分别在水(6cm)/肺(6cm)/水(8cm)、水(6cm)/骨骼(2cm)/水(12cm)非均匀组织的百分深度剂量曲线;③6MeV单能光子6cm×6cm照射野人体头部和腹部组织在射野内和射野外的百分深度剂量曲线。比较DPM计算值与DOSXYZnrc/EGSnrc系统在相同条件下的计算值。结果显示二者计算值在水模中的误差在±3%以内,在非均匀组织中,除了个别点,误差都在±3%以内。DPM能够精确计算均匀组织和非均匀组织剂量。     

A Monte Carlo model of the Varian IGRT couch top for RapidArc QA

The objectives of this study are to evaluate the effect of couch attenuation on quality assurance (QA) results and to present a couch top model for Monte Carlo (MC) dose calculation for RapidArc treatments. The IGRT couch top is modelled in Eclipse as a thin skin of higher density material with a homogeneous fill of foam of lower density and attenuation. The IGRT couch structure consists of two longitudinal sections referred to as thick and thin. The Hounsfield Unit (HU) characterization of the couch structure was determined using a cylindrical phantom by comparing ion chamber measurements with the dose predicted by the treatment planning system (TPS). The optimal set of HU for the inside of the couch and the surface shell was found to be respectively -960 and -700 HU in agreement with Vanetti et al (2009 Phys. Med. Biol. 54 N157-66). For each plan, the final dose calculation was performed with the thin, thick and without the couch top. Dose differences up to 2.6% were observed with TPS calculated doses not including the couch and up to 3.4% with MC not including the couch and were found to be treatment specific. A MC couch top model was created based on the TPS geometrical model. The carbon fibre couch top skin was modelled using carbon graphite; the density was adjusted until good agreement with experimental data was observed, while the density of the foam inside was kept constant. The accuracy of the couch top model was evaluated by comparison with ion chamber measurements and TPS calculated dose combined with a 3D gamma analysis. Similar to the TPS case, a single graphite density can be used for both the thin and thick MC couch top models. Results showed good agreement with ion chamber measurements (within 1.2%) and with TPS (within 1%). For each plan, over 95% of the points passed the 3D gamma test.     

Peripheral dose measurements for 6 and 18 MV photon beams on a linear accelerator with multileaf collimator

Peripheral dose (PD) to critical structures outside treatment volume is of clinical importance. The aim of the current study was to estimate PD on a linear accelerator equipped with multileaf collimator (MLC). Dose measurements were carried out using an ionization chamber embedded in a water phantom for 6 and 18 MV photon beams. PD values were acquired for field sizes from 5 x 5 to 20 x 20 cm2 in increments of 5 cm at distances up to 24 cm from the field edge. Dose data were obtained at two collimator orientations where the measurement points are shielded by MLC and jaws. The variation of PD with the source to skin distance (SSD), depth, and lateral displacement of the measurement point was evaluated. To examine the dependence of PD upon the tissue thickness at the entrance point of the beam, scattered dose was measured using thermoluminescent dosemeters placed on three anthropomorphic phantoms simulating 5- and 10-year-old children and an average adult patient. PD from 6 MV photons varied from 0.13% to 6.75% of the central-axis maximum dose depending upon the collimator orientation, extent of irradiated area, and distance from the treatment field. The corresponding dose range from 18 MV x rays was 0.09% to 5.61%. The variation of PD with depth and with lateral displacements up to 80% of the field dimension was very small. The scattered dose from both photon beams increased with the increase of SSD or tissue thickness along beam axis. The presented dosimetric data set allows the estimation of scattered dose outside the primary beam.     

Modeling skin collimation using the electron pencil beam redefinition algorithm

Skin collimation is an important tool for electron beam therapy that is used to minimize the penumbra when treating near critical structures, at extended treatment distances, with bolus, or using arc therapy. It is usually made of lead or lead alloy material that conforms to and is placed on patient surface. Presently, commercially available treatment-planning systems lack the ability to model skin collimation and to accurately calculate dose in its presence. The purpose of the present work was to evaluate the use of the pencil beam redefinition algorithm (PBRA) in calculating dose in the presence of skin collimation. Skin collimation was incorporated into the PBRA by terminating the transport of electrons once they enter the skin collimator. Both fixed- and arced-beam dose calculations for arced-beam geometries were evaluated by comparing them with measured dose distributions for 10- and 15-MeV beams. Fixed-beam dose distributions were measured in water at 88-cm source-to-surface distance with an air gap of 32 cm. The 6 x 20-cm2 field (dimensions projected to isocenter) had a 10-mm thick lead collimator placed on the surface of the water with its edge 5 cm inside the field's edge located at +10 cm. Arced-beam dose distributions were measured in a 13.5-cm radius polystyrene circular phantom. The beam was arced 90 degrees (-45 degrees to +45 degrees), and 10-mm thick lead collimation was placed at +/- 30 degrees. For the fixed beam at 10 MeV, the PBRA- calculated dose agreed with measured dose to within 2.0-mm distance to agreement (DTA) in the regions of high-dose gradient and 2.0% in regions of low dose gradient. At 15 MeV, the PBRA agreed to within a 2.0-mm DTA in the regions of high-dose gradient; however, the PBRA underestimated the dose by as much as 5.3% over small regions at depths less than 2 cm because it did not model electrons scattered from the edge of the skin collimation. For arced beams at 10 MeV, the agreement was 1-mm DTA in the high-dose gradient regions, and 2% in the low-dose gradient regions. For arced beams at 15 MeV, the agreement was 1 mm in the high-dose gradient regions, and in the low-dose gradient region at depth less than 2 cm, as much as 5% dose difference was observed. This study demonstrated the ease with which skin collimation can be incorporated into the PBRA. The good agreement of PBRA calculated with measured dose shows that the PBRA is likely sufficiently accurate for clinical use in the presence of skin collimation for electron arc therapy. To further improve the accuracy of the PBRA in regions having significant electrons scattered from the edge of the skin collimation would require transporting the electrons through the lead skin collimation near its edges.     

Total skin electron therapy treatment verification: Monte Carlo simulation and beam characteristics of large non-standard electron fields

Total skin electron therapy (TSET) is a complex technique which requires non-standard measurements and dosimetric procedures. This paper investigates an essential first step towards TSET Monte Carlo (MC) verification. The non-standard 6 MeV 40 x 40 cm2 electron beam at a source to surface distance (SSD) of 100 cm as well as its horizontal projection behind a polymethylmethacrylate (PMMA) screen to SSD = 380 cm were evaluated. The EGS4 OMEGA-BEAM code package running on a Linux home made 47 PCs cluster was used for the MC simulations. Percentage depth-dose curves and profiles were calculated and measured experimentally for the 40 x 40 cm2 field at both SSD = 100 cm and patient surface SSD = 380 cm. The output factor (OF) between the reference 40 x 40 cm2 open field and its horizontal projection as TSET beam at SSD = 380 cm was also measured for comparison with MC results. The accuracy of the simulated beam was validated by the good agreement to within 2% between measured relative dose distributions, including the beam characteristic parameters (R50, R80, R100, Rp, E0) and the MC calculated results. The energy spectrum, fluence and angular distribution at different stages of the beam (at SSD = 100 cm, at SSD = 364.2 cm, behind the PMMA beam spoiler screen and at treatment surface SSD = 380 cm) were derived from MC simulations. Results showed a final decrease in mean energy of almost 56% from the exit window to the treatment surface. A broader angular distribution (FWHM of the angular distribution increased from 13 degrees at SSD = 100 cm to more than 30 degrees at the treatment surface) was fully attributable to the PMMA beam spoiler screen. OF calculations and measurements agreed to less than 1%. The effect of changing the electron energy cut-off from 0.7 MeV to 0.521 MeV and air density fluctuations in the bunker which could affect the MC results were shown to have a negligible impact on the beam fluence distributions. Results proved the applicability of using MC as a treatment verification tool for complex radiotherapy techniques.